$1.34
+0.10 (+8.06%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+419.4% upside
Low Target
$5.52
Average Target
$6.96
High Target
$10.50
Current Price
$1.34
Current
$1.34
$1.34
Target
$6.96
$6.96
$5.52
$6.96 avg
$10.50
Scenario Analysis
Bear Case
$5.52
311.9%
Low target
Base Case
$6.96
+419.4%
Avg target
Bull Case
$10.50
+683.6%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$1.88
-28.7% from high
52-Week Low
$0.81
+65.4% from low
Target vs 52W High
$6.96
+270.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +19.8% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.0% |
| GILD | Strong Buy | 38 | 79% | $362.68 | +158.5% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -2.0% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.1% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -13.0% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -29.7% |